Search results
Will BioCryst Pharmaceuticals (BCRX) Report Negative Earnings Next Week? What You Should Know
Zacks via Yahoo Finance· 2 years agoBioCryst (BCRX) doesn't possess the right combination of the two key ingredients for a likely...
BioCryst Pharmaceuticals Inc (BCRX) Reports Growth in ORLADEYO Revenue and Projects ...
GuruFocus.com via Yahoo Finance· 3 months agoORLADEYO Revenue: Q4 net revenue of $90.9 million, contributing to $326.0 million for FY 2023,...
Wall Street Analysts Think BioCryst (BCRX) Could Surge 107.2%: Read This Before Placing a Bet
Zacks via Yahoo Finance· 10 months agoThe average of price targets set by Wall Street analysts indicates a potential upside of 107.2% in...
BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) recent 18% pullback adds to one-year year losses,...
Simply Wall St. via Yahoo Finance· 6 months agoKey Insights Given the large stake in the stock by institutions, BioCryst Pharmaceuticals' stock...
BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) institutional shareholders had a great week as...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Given the large stake in the stock by institutions, BioCryst Pharmaceuticals' stock...
BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoBioCryst (BCRX) delivered earnings and revenue surprises of 28.13% and 3.23%, respectively, for the...
BioCryst Pharmaceuticals (NASDAQ:BCRX) investors are sitting on a loss of 48% if they invested a...
Simply Wall St. via Yahoo Finance· 5 months agoBioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shareholders should be happy to see the share price up...
Why Earnings Season Could Be Great for BioCryst (BCRX)
Zacks via Yahoo Finance· 1 year agoInvestors are always looking for stocks that are poised to beat at earnings season and BioCryst...
Here's What BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) Shareholder Ownership Structure Looks...
Simply Wall St. via Yahoo Finance· 2 years agoA look at the shareholders of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) can tell us which group...
With 80% ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) boasts of strong institutional...
Simply Wall St. via Yahoo Finance· 1 month agoKey Insights Significantly high institutional ownership implies BioCryst Pharmaceuticals' stock...